pVITRO1-Trastuzumab-IgG1/κ Citations (12)
Originally described in: A tool kit for rapid cloning and expression of recombinant antibodies.Dodev TS, Karagiannis P, Gilbert AE, Josephs DH, Bowen H, James LK, Bax HJ, Beavil R, Pang MO, Gould HJ, Karagiannis SN, Beavil AJ Sci Rep. 2014 Jul 30;4:5885. doi: 10.1038/srep05885. PubMed Journal
Articles Citing pVITRO1-Trastuzumab-IgG1/κ
| Articles |
|---|
| A Simple and Sensitive High-Content Assay for the Characterization of Antiproliferative Therapeutic Antibodies. Stengl A, Horl D, Leonhardt H, Helma J. J Biomol Screen. 2016 Dec 1. pii: 1087057116677821. PubMed |
| Laboratory Scale Production and Purification of a Therapeutic Antibody. Elgundi Z, Sifniotis V, Reslan M, Cruz E, Kayser V. J Vis Exp. 2017 Jan 24;(119). doi: 10.3791/55153. PubMed |
| Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody-Drug Conjugate. Cox EC, Thornlow DN, Jones MA, Fuller JL, Merritt JH, Paszek MJ, Alabi CA, DeLisa MP. Cancer Res. 2019 Apr 15;79(8):1810-1821. doi: 10.1158/0008-5472.CAN-18-3119. Epub 2019 Feb 26. PubMed |
| High-Affinity Antibody Detection with a Bivalent Circularized Peptide Containing Antibody-Binding Domains. Zhou F, Kroetsch A, Nguyen VP, Huang X, Ogoke O, Parashurama N, Park S. Biotechnol J. 2019 May;14(5):e1800647. doi: 10.1002/biot.201800647. Epub 2019 Apr 15. PubMed |
| A simple approach to identify functional antibody variable genes in murine hybridoma cells that coexpress aberrant kappa light transcripts by restriction enzyme digestion. Kraivong R, Luangaram P, Phaenthaisong N, Malasit P, Kasinrerk W, Puttikhunt C. Asian Pac J Allergy Immunol. 2019 Jun 4. doi: 10.12932/ 10.12932/AP-031218-0452. PubMed |
| Enhancing the stability of adalimumab by engineering additional glycosylation motifs. Reslan M, Sifniotis V, Cruz E, Sumer-Bayraktar Z, Cordwell S Prof, Kayser V. Int J Biol Macromol. 2020 Apr 29;158:189-196. doi: 10.1016/j.ijbiomac.2020.04.147. PubMed |
| Development of a Proline-Based Selection System for Reliable Genetic Engineering in Chinese Hamster Ovary Cells. Sun T, Kwok WC, Chua KJ, Lo TM, Potter J, Yew WS, Chesnut JD, Hwang IY, Chang MW. ACS Synth Biol. 2020 Jul 17;9(7):1864-1872. doi: 10.1021/acssynbio.0c00221. Epub 2020 Jun 12. PubMed |
| Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria. Natarajan A, Jaroentomeechai T, Cabrera-Sanchez M, Mohammed JC, Cox EC, Young O, Shajahan A, Vilkhovoy M, Vadhin S, Varner JD, Azadi P, DeLisa MP. Nat Chem Biol. 2020 Oct;16(10):1062-1070. doi: 10.1038/s41589-020-0595-9. Epub 2020 Jul 27. PubMed |
| Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V. Pharmaceutics. 2021 Oct 20;13(11). pii: pharmaceutics13111747. doi: 10.3390/pharmaceutics13111747. PubMed |
| Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS. Zinngrebe J, Moepps B, Monecke T, Gierschik P, Schlichtig F, Barth TFE, Strauss G, Boldrin E, Posovszky C, Schulz A, Beringer O, Rieser E, Jacobsen EM, Lorenz MR, Schwarz K, Pannicke U, Walczak H, Niessing D, Schuetz C, Fischer-Posovszky P, Debatin KM. EMBO Mol Med. 2022 Mar 7;14(3):e14901. doi: 10.15252/emmm.202114901. Epub 2022 Feb 16. PubMed |
| A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans. Jaroentomeechai T, Kwon YH, Liu Y, Young O, Bhawal R, Wilson JD, Li M, Chapla DG, Moremen KW, Jewett MC, Mizrachi D, DeLisa MP. Nat Commun. 2022 Oct 24;13(1):6325. doi: 10.1038/s41467-022-34029-7. PubMed |
Engineered cell entry links receptor biology with single-cell genomics.
Yu B, Shi Q, Belk JA, Yost KE, Parker KR, Li R, Liu BB, Huang H, Lingwood D, Greenleaf WJ, Davis MM, Satpathy AT, Chang HY.
Cell. 2022 Dec 22;185(26):4904-4920.e22. doi: 10.1016/j.cell.2022.11.016. Epub 2022 Dec 13.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.